Search Results - "Mander, Alastair"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin by MOORE, Eileen M, MANDER, Alastair G, FAUX, Noel G, MARTINS, Ralph, SZOEKE, Cassandra, ROWE, Christopher, WATTERS, David A, AMES, David, KOTOWICZ, Mark A, CARNE, Ross P, BRODATY, Henry, WOODWARD, Michael, BOUNDY, Karyn, ELLIS, Kathryn A, BUSH, Ashley I

    Published in Diabetes care (01-10-2013)
    “…To investigate the associations of metformin, serum vitamin B12, calcium supplements, and cognitive impairment in patients with diabetes. Participants were…”
    Get full text
    Journal Article
  2. 2

    Cognitive impairment and vitamin B12: a review by Moore, Eileen, Mander, Alastair, Ames, David, Carne, Ross, Sanders, Kerrie, Watters, David

    Published in International psychogeriatrics (01-04-2012)
    “…This review examines the associations between low vitamin B12 levels, neurodegenerative disease, and cognitive impairment. The potential impact of…”
    Get more information
    Journal Article
  3. 3

    Predictors of Mortality in Dementia: The PRIME Study by Connors, Michael H, Ames, David, Boundy, Karyn, Clarnette, Roger, Kurrle, Sue, Mander, Alastair, Ward, John, Woodward, Michael, Brodaty, Henry

    Published in Journal of Alzheimer's disease (23-05-2016)
    “…Dementia is a terminal illness. While various baseline characteristics of patients, such as age, sex, and dementia severity, are known to predict mortality,…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Mortality in Mild Cognitive Impairment: A Longitudinal Study in Memory Clinics by Connors, Michael H, Ames, David, Boundy, Karyn, Clarnette, Roger, Kurrle, Sue, Mander, Alastair, Ward, John, Woodward, Michael, Brodaty, Henry

    Published in Journal of Alzheimer's disease (23-08-2016)
    “…Patients with mild cognitive impairment (MCI) are at greater risk of mortality than the general population. Comparatively little research has examined…”
    Get more information
    Journal Article
  8. 8

    A revolution in drug approval practices is required by Mander, Alastair

    Published in BMJ (Online) (26-11-2012)
    “…The manufacturer could thus market the drug and start to recoup its investment, while the public and medical community obtain further data on the role and…”
    Get full text
    Journal Article
  9. 9

    Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months by Thai, Christine, Lim, Yen Ying, Villemagne, Victor L, Laws, Simon M, Ames, David, Ellis, Kathryn A, Rainey-Smith, Stephanie R, Martins, Ralph N, Masters, Colin L, Rowe, Christopher C, Maruff, Paul

    Published in PloS one (02-10-2015)
    “…High levels of β-amyloid (Aβ) in the brain and carriage of the APOE ε4 allele have each been linked to cognitive impairment in cognitively normal (CN) older…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease by Angelis, Pela, Scharf, Simon, Mander, Alastair, Vajda, Frank, Christophidis, Nicholas

    Published in Neuroscience letters (13-03-1998)
    “…Serum levels of interleukin-6 (IL-6) and interleukin-6 soluble receptor (IL-6sR) were measured in 41 patients (23 female and 18 male, mean age 72.5 years) with…”
    Get full text
    Journal Article
  13. 13

    Fluoxetine induced dyskinesia by Mander, A, McCausland, M, Workman, B, Flamer, H, Christophidis, N

    “…A case of fluoxetine induced dyskinesia in an elderly woman with previous use of low dose haloperidol is described. In contrast to neuroleptic induced tardive…”
    Get more information
    Journal Article